Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

[Treatment of HIV in Pregnancy - Progress Over One Decade].

Pitzen IC, Otten LA, Dresbach T, Boesecke C, Wasmuth JC, Mueller A, Gembruch U, Merz WM, Strassburg CP, Haberl A, Rockstroh JK, Poralla S, Schwarze-Zander C.

Z Geburtshilfe Neonatol. 2019 Feb;223(1):26-32. doi: 10.1055/a-0741-7700. Epub 2018 Dec 4. German.

PMID:
30513543
2.

Pravastatin for prevention of HELLP syndrome: A case report.

Otten LA, van der Ven K, Kühr M, Gembruch U, Merz WM.

Medicine (Baltimore). 2017 Oct;96(42):e8229. doi: 10.1097/MD.0000000000008229.

3.

Comparison of radiofrequency kyphoplasty and balloon kyphoplasty in combination with posterior fixation for the treatment of vertebral fractures.

Bornemann R, Jansen TR, Otten LA, Sander K, Wirtz DC, Pflugmacher R.

J Back Musculoskelet Rehabil. 2017;30(3):591-596. doi: 10.3233/BMR-140224.

PMID:
28035907
4.

[Radiofrequency kyphoplasty combined with posterior fixation in the treatment of burst fractures].

Jansen T, Bornemann R, Otten LA, Kabir K, Wirtz D, Sander K, Pflugmacher R.

Z Orthop Unfall. 2013 Dec;151(6):632-7. doi: 10.1055/s-0033-1351062. Epub 2013 Dec 17. German.

PMID:
24347417
5.

Comparison of balloon kyphoplasty with the new Kiva® VCF system for the treatment of vertebral compression fractures.

Otten LA, Bornemnn R, Jansen TR, Kabir K, Pennekamp PH, Wirtz DC, Stuwe B, Pflugmacher R.

Pain Physician. 2013 Sep-Oct;16(5):E505-12.

6.

[Kiva® VCF Treatment System - clinical study on the efficacy and patient safety of a new system for augmentation of vertebral compression fractures].

Bornemann R, Otten LA, Koch EM, Jansen TR, Kabir K, Wirtz DC, Pflugmacher R.

Z Orthop Unfall. 2012 Dec;150(6):572-8. doi: 10.1055/s-0032-1327935. Epub 2013 Jan 7. German.

PMID:
23296554
7.

Novel murine dendritic cell lines: a powerful auxiliary tool for dendritic cell research.

Fuertes Marraco SA, Grosjean F, Duval A, Rosa M, Lavanchy C, Ashok D, Haller S, Otten LA, Steiner QG, Descombes P, Luber CA, Meissner F, Mann M, Szeles L, Reith W, Acha-Orbea H.

Front Immunol. 2012 Nov 7;3:331. doi: 10.3389/fimmu.2012.00331. eCollection 2012.

8.

[Radiofrequency kyphoplasty - an innovative method for the treatment of vertebral compression fractures - comparison with conservative treatment].

Bornemann R, Kabir K, Otten LA, Deml M, Koch EM, Wirtz DC, Pflugmacher R.

Z Orthop Unfall. 2012 Sep;150(4):392-6. doi: 10.1055/s-0031-1298547. Epub 2012 Aug 23. German.

PMID:
22918825
9.

[Comparative findings of balloon kyphoplasty in patients with vertebral fractures due to osteoporosis, metastases and myeloma].

Pflugmacher R, Bornemann R, Koch EM, Hausmann D, Otten LA, Goost H, Wirtz D, Kabir K.

Z Orthop Unfall. 2012 Apr;150(2):198-204. doi: 10.1055/s-0031-1280230. Epub 2011 Nov 7. German.

PMID:
22065377
10.

CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche.

Chevrier S, Genton C, Kallies A, Karnowski A, Otten LA, Malissen B, Malissen M, Botto M, Corcoran LM, Nutt SL, Acha-Orbea H.

Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3895-900. doi: 10.1073/pnas.0809736106. Epub 2009 Feb 19.

11.

The NLR gene family: a standard nomenclature.

Ting JP, Lovering RC, Alnemri ES, Bertin J, Boss JM, Davis BK, Flavell RA, Girardin SE, Godzik A, Harton JA, Hoffman HM, Hugot JP, Inohara N, Mackenzie A, Maltais LJ, Nunez G, Ogura Y, Otten LA, Philpott D, Reed JC, Reith W, Schreiber S, Steimle V, Ward PA.

Immunity. 2008 Mar;28(3):285-7. doi: 10.1016/j.immuni.2008.02.005. No abstract available.

12.

In vivo transformation of mouse conventional CD8alpha+ dendritic cells leads to progressive multisystem histiocytosis.

Steiner QG, Otten LA, Hicks MJ, Kaya G, Grosjean F, Saeuberli E, Lavanchy C, Beermann F, McClain KL, Acha-Orbea H.

Blood. 2008 Feb 15;111(4):2073-82. Epub 2007 Nov 20.

13.

Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells.

Meier D, Bornmann C, Chappaz S, Schmutz S, Otten LA, Ceredig R, Acha-Orbea H, Finke D.

Immunity. 2007 May;26(5):643-54.

14.

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). 1993.

Steimle V, Otten LA, Zufferey M, Mach B.

J Immunol. 2007 Jun 1;178(11):6677-88. No abstract available.

15.

Revisiting the specificity of the MHC class II transactivator CIITA in vivo.

Otten LA, Leibundgut-Landmann S, Huarte J, Kos-Braun IC, Lavanchy C, Barras E, Borisch B, Steimle V, Acha-Orbea H, Reith W.

Eur J Immunol. 2006 Jun;36(6):1548-58.

16.

Notch1 expression on T cells is not required for CD4+ T helper differentiation.

Tacchini-Cottier F, Allenbach C, Otten LA, Radtke F.

Eur J Immunol. 2004 Jun;34(6):1588-96.

17.

Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes.

LeibundGut-Landmann S, Waldburger JM, Krawczyk M, Otten LA, Suter T, Fontana A, Acha-Orbea H, Reith W.

Eur J Immunol. 2004 Jun;34(6):1513-25. Review.

18.

Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response.

Didierlaurent A, Ferrero I, Otten LA, Dubois B, Reinhardt M, Carlsen H, Blomhoff R, Akira S, Kraehenbuhl JP, Sirard JC.

J Immunol. 2004 Jun 1;172(11):6922-30.

19.

Passive immunization with neutralizing antibodies interrupts the mouse mammary tumor virus life cycle.

Mpandi M, Otten LA, Lavanchy C, Acha-Orbea H, Finke D.

J Virol. 2003 Sep;77(17):9369-77.

20.

Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes.

Otten LA, Tacchini-Cottier F, Lohoff M, Annunziato F, Cosmi L, Scarpellino L, Louis J, Steimle V, Reith W, Acha-Orbea H.

J Immunol. 2003 Feb 1;170(3):1150-7.

21.

Experimental models of transcription factor-associated maturity-onset diabetes of the young.

Wang H, Hagenfeldt-Johansson K, Otten LA, Gauthier BR, Herrera PL, Wollheim CB.

Diabetes. 2002 Dec;51 Suppl 3:S333-42. Review.

22.

Can MMTV exploit TLR4?

Otten LA, Finke D, Acha-Orbea H.

Trends Microbiol. 2002 Jul;10(7):303-5; discussion 305-6. Review.

PMID:
12110201
23.

Quantitative control of MHC class II expression by the transactivator CIITA.

Otten LA, Steimle V, Bontron S, Mach B.

Eur J Immunol. 1998 Feb;28(2):473-8.

24.
26.
27.

A rapid micro scale method for the detection of lysopine and nopaline dehydrogenase activities.

Otten LA, Schilperoort RA.

Biochim Biophys Acta. 1978 Dec 8;527(2):497-500.

PMID:
31918
28.

Properties of D(+)-lysopine dehydrogenase from crown gall tumour tissue.

Otten LA, Vreugdenhil D, Schilperoort RA.

Biochim Biophys Acta. 1977 Dec 8;485(2):268-77.

PMID:
21695

Supplemental Content

Loading ...
Support Center